Search for: "Sanofi-Aventis, U.S., Inc." Results 101 - 120 of 120
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2009, 2:36 pm
The last big pharmaceutical industry acquisition came in August 2004, when Paris-based Sanofi-Synthelabo acquired Aventis SA of Strasburg, France, for $64.4 billion to create Sanofi Aventis SA, France's largest drugmaker. [read post]
8 Jan 2009, 12:38 pm
  On March 31, 2005, one year into the FDA review of the generic manufacturers' ANDA submissions, Defendants Aventis Pharmaceuticals, Inc., Sanofi-Aventis, and Sanofi-Aventi U.S., LLC (collectively "Aventis") filed a Citizen Petition pursuant to Section 505(j) of the Federal Food, Drug, and Cosmetic Act. [read post]
13 Sep 2008, 4:35 am
Recent news reports have allowed us to add four more companies to the list: • Sanofi-Aventis' U.S. subsidiary spent more than $1.2 million on second quarter lobbying (see Forbes.com report). [read post]
2 Sep 2008, 12:39 am
Sanofi-Aventis et al. v. [read post]
22 Feb 2008, 1:30 pm
Bart Stupak argued for years that the U.S. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
6 Sep 2007, 2:56 pm
Ketek can still be used to treat certain types of pneumonia.More information about these restrictions imposed on Ketek in Canada are set forth in the accompanying "PUBLIC COMMUNICATION Health Canada Endorsed Important Safety Information on KETEK (telithromycin)" and the the so-called "Dear Doctor" letter sent to health care professionals by Sanofi-aventis Canada Inc. on August 30, 2007. [read post]
19 Jun 2007, 9:45 pm
By Donald Zuhn -- Sanofi-Aventis and Bristol-Myers Squibb announced today (June 19, 2007) that the U.S. [read post]
17 Jun 2007, 7:53 pm
Sanofi-Aventis U.S. [read post]
9 Feb 2007, 11:37 am
Singer In a February 9, 2007 press release, Sanofi-Aventis announced that it has lost its patent infringement suit against generic drugmakers Amphastar Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd., filed in the U.S. [read post]
26 Jan 2007, 6:09 am
In August 2006, generic drug maker Apotex Inc. began selling a cheaper version of Plavix, a blood thinner Bristol-Myers co-markets with Sanofi-Aventis SA, after an agreement to settle a patent dispute fell apart. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
15 Aug 2006, 6:45 am
Sanofi-Aventis SA and Bristol-Myers Squibb filed for a preliminary injunction against Apotex Inc . to stop sales of a generic version of Plavix ® (clopidogrel bisulfate). [read post]
9 Aug 2006, 9:46 am
Apotex Inc. must be confident the patent on Plavix will be held invalid. [read post]
23 Mar 2006, 10:15 pm
Bristol-Myers Squibb Company and sanofi-aventis announced earlier this week that they have reached a tentative settlement agreement with Apotex Inc. and Apotex Corp. regarding the pending Plavix ® patent infringement lawsuit. [read post]